Klinisk Biokemi i Norden · 4 2015
| 19
Referencer:
1. European Colorectal Cancer Screening Gui-
delines Working Group, von Karsa L, Pat-
nick J, Segnan N, Atkin W, Halloran S, et al.
European guidelines for quality assurance in
colorectal cancer screening and diagnosis:
overview and introduction to the full supple-
ment publication. Endoscopy 2013;45:51-9.
2. NORDCAN projektet: NORDCAN Associa-
tion of the Nordic Cancer Registries; 2011
[cited 2014 10-09-2014]. Available from: http://
www-dep.iarc.fr/NORDCAN/DK/frame.asp.
3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent
J, Rosso S, Coebergh JW, Comber H, et al.
Cancer incidence and mortality patterns in
Europe: estimates for 40 countries in 2012.
Euro J Cancer. 2013;49:1374-403.
4. European guidelines for quality assurance
in colorectal cancer screening and diagnosis.
Luxemburg: Publications Office of the Euro-
pean Union: European Union, 2010.
5. Kanavos P, Schurer W. The dynamics of colo-
rectal cancer management in 17 countries. Eur
J Health Econ 2010;10 Suppl 1:S115-29.
6. Vogelaar IvB, M.; Zauber, A. G. Model profiler
of the MISCAN-COLON simulation model
for evaluation of colorectal cancer screening.
Comput Biomed Res. 1999;32:13-33.
7. Lindebjerg J, Osler M, Bisgaard C. Colorectal
cancers detected through screening are asso-
ciated with lower stages and improved survi-
val. Dan Med J. 2014;61:A4758.
8. Anbefalinger vedrørende screening for tyk- og
endetarmskræft. 2012.
9. Krausing JH. Manual for implementering
og drift af tværregional tarmkræftscreening.
Copenhagen, Denmark: 2014 17-09-2014.
Report No.: 25467/13
10. Hol L, Wilschut JA, van Ballegooijen M, van
Vuuren AJ, van der Valk H, Reijerink JC, et
al. Screening for colorectal cancer: random
comparison of guaiac and immunochemical
faecal occult blood testing at different cut-off
levels. Brit J Cancer. 2009;100:1103-10.
11. Young G. Fecal Immunochemical Tests (FIT)
vs. Office-Based Guaiac Fecal Occult Blood
Test (FOBT). Pract Gastroenterol. 2004.
12. Young GP, Symonds EL, Allison JE, Cole SR,
Fraser CG, Halloran SP, et al. Advances in fecal
occult blood tests: the FIT revolution. Dig Dis
Sci. 2015;60:609-22.
13. Screening Danish Colorectal Cancer Group,
2014.
14. van Rossum LG, van Rijn AF, Laheij RJ, van
Oijen MG, Fockens P, Jansen JB, et al. Cutoff
value determines the performance of a semi-
quantitative immunochemical faecal occult
blood test in a colorectal cancer screening
programme. Brit J Cancer. 2009;101:1274-81.
15. Plum I. HK15 F-Hæmoglobin Langtidskontrol,
EQA-serum. 1 ed: DEKS; 2015.
16. Plum I. Blod i fæces. Dansk Institut for Ekstern
Kvalitetssikring for Laboratorier i Sundheds-
sektoren, 2014.
17. Wilschut JA, Habbema JDF, van Leerdam
ME, Hol L, Lansdorp-Vogelaar I, Kuipers EJ,
et al. Fecal occult blood testing when colono-
scopy capacity is limited. J Natl Cancer Inst.
2011;103:1741-51.
Olivträd på Puig de Massanellas sluttning.
Foto: Henrik Alfthan.
